ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$16.740-0.430 (-2.504%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$17.170

Haut

$17.490

Bas

$16.685

Volume

1.22M

Fondamentaux de l'Entreprise

Capitalisation Boursière

2.3B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.84M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $9.57Actuel $16.740Haut $30.41

Actualités Connexes

BusinessWire

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity

ARO-ALK7 is the first investigational RNAi therapeutic to enter clinical studies that targets a gene expressed in adipose tissue Study initiation highlights Arrowhead's leadership in the delivery of siRNA to

Voir plus
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
BusinessWire

Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming investor events: Jefferies Global Healthcare Conference – June 4-5, 2025 Type: Fireside

Voir plus
Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma with a Buy and maintains $80 price target.

Voir plus
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.